Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Nov 21 IMVT Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?
Nov 21 SPRO JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer
Nov 21 GNFT Genfit Balances Ipsen Partnership With High-Risk Pipeline Ambitions
Nov 20 FATE Fate Therapeutics: FT819 Finding Bodes Well For Future Of SLE Treatment Options
Nov 20 SPRO Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
Nov 20 CGON CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting
Nov 19 SPRO FATE Presents Encourgaing Data From Lupus Study, Stock Gains
Nov 19 FOLD HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
Nov 19 SPRO CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
Nov 19 FATE Wall Street Breakfast Podcast: Fate Therapeutics Rises On Lupus Drug Data
Nov 19 ANNX The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate.
Nov 18 FATE Fate Therapeutics Shares Rise After 'Promising' Lupus Treatment Results
Nov 18 SPRO TenNor’s Phase III antibiotic trial meets all primary endpoints
Nov 18 FATE Fate stock rallies 37% on positive Phase 1 data for FT819, FT522
Nov 18 ARTL Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
Nov 18 FATE Fate Therapeutics Presents 6-Month Follow-up Data on First Patient Treated in Phase 1 Autoimmunity Study with Fludarabine-free Conditioning and FT819 Off-the-shelf, 1XX CAR T-cell Product Candidate at ACR Convergence
Nov 18 FATE Fate Therapeutics Highlights FT522 Off-the-shelf, ADR-armed CAR NK Cell Product Candidate at 2024 ACR Convergence
Nov 18 SPRO CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
Nov 18 APGE Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
Nov 17 SPRO Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags